APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single Nucleotide Polymorphism (SNP) Genotyping

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Selected research

Industry Growth & Trends

Global Single Nucleotide Polymorphism (SNP) Genotyping Industry Growth and Trends Forecast to 2032

20 December 2025124 pages

Choose your research edition.

Industry ResearchSingle Nucleotide Polymorphism (SNP) Genotyping Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Nucleotide Polymorphism (SNP) Genotyping Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Single Nucleotide Polymorphism (SNP) Genotyping Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

According to APO Research, the global Single Nucleotide Polymorphism (SNP) Genotyping market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Single Nucleotide Polymorphism (SNP) Genotyping market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Single Nucleotide Polymorphism (SNP) Genotyping market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Single Nucleotide Polymorphism (SNP) Genotyping market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Single Nucleotide Polymorphism (SNP) Genotyping.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Single Nucleotide Polymorphism (SNP) Genotyping market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Single Nucleotide Polymorphism (SNP) Genotyping Market by Company

Illumina

Affymetrix

Applied Biosystems

Agilent Technologies

Beckman Coulter

Roche

Qiagen

Luminex Corporation

Enzo Life Sciences

Bio-rad

Sequenom

Ocimum Biosolutions

GE Healthcare

GenScript

Douglas Scientific

BGI

Beijing Sunbiotech

HuaGene Biotech

Generay Biotech

Benegene

Shanghai Biochip

GENESKY

HD Biosciences

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type

Transversion

Transition

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application

Diagnostics

Animal

Plant

Research

Others

Single Nucleotide Polymorphism (SNP) Genotyping Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Nucleotide Polymorphism (SNP) Genotyping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Nucleotide Polymorphism (SNP) Genotyping and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Nucleotide Polymorphism (SNP) Genotyping.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Single Nucleotide Polymorphism (SNP) Genotyping companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2021-2026) Table 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2027-2032) Table 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2026) Table 9. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share Forecasted by Type (2027-2032) Table 11. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2026) Table 24. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share Forecasted by Application (2027-2032) Table 26. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends Table 37. Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers Table 38. Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges Table 39. Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints Table 40. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Company (2021-2026) Table 42. Global Single Nucleotide Polymorphism (SNP) Genotyping Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Single Nucleotide Polymorphism (SNP) Genotyping Key Company Headquarters & Area Served Table 44. Global Single Nucleotide Polymorphism (SNP) Genotyping Company, Product Type & Application Table 45. Global Single Nucleotide Polymorphism (SNP) Genotyping Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Single Nucleotide Polymorphism (SNP) Genotyping by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 52. Illumina Recent Development Table 53. Affymetrix Company Information Table 54. Affymetrix Business Overview Table 55. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 57. Affymetrix Recent Development Table 58. Applied Biosystems Company Information Table 59. Applied Biosystems Business Overview Table 60. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 62. Applied Biosystems Recent Development Table 63. Agilent Technologies Company Information Table 64. Agilent Technologies Business Overview Table 65. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 67. Agilent Technologies Recent Development Table 68. Beckman Coulter Company Information Table 69. Beckman Coulter Business Overview Table 70. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 72. Beckman Coulter Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 77. Roche Recent Development Table 78. Qiagen Company Information Table 79. Qiagen Business Overview Table 80. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 82. Qiagen Recent Development Table 83. Luminex Corporation Company Information Table 84. Luminex Corporation Business Overview Table 85. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 87. Luminex Corporation Recent Development Table 88. Enzo Life Sciences Company Information Table 89. Enzo Life Sciences Business Overview Table 90. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 92. Enzo Life Sciences Recent Development Table 93. Bio-rad Company Information Table 94. Bio-rad Business Overview Table 95. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 97. Bio-rad Recent Development Table 98. Sequenom Company Information Table 99. Sequenom Business Overview Table 100. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 102. Sequenom Recent Development Table 103. Ocimum Biosolutions Company Information Table 104. Ocimum Biosolutions Business Overview Table 105. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 107. Ocimum Biosolutions Recent Development Table 108. GE Healthcare Company Information Table 109. GE Healthcare Business Overview Table 110. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 112. GE Healthcare Recent Development Table 113. GenScript Company Information Table 114. GenScript Business Overview Table 115. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 117. GenScript Recent Development Table 118. Douglas Scientific Company Information Table 119. Douglas Scientific Business Overview Table 120. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 122. Douglas Scientific Recent Development Table 123. BGI Company Information Table 124. BGI Business Overview Table 125. BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 127. BGI Recent Development Table 128. Beijing Sunbiotech Company Information Table 129. Beijing Sunbiotech Business Overview Table 130. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 132. Beijing Sunbiotech Recent Development Table 133. HuaGene Biotech Company Information Table 134. HuaGene Biotech Business Overview Table 135. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 137. HuaGene Biotech Recent Development Table 138. Generay Biotech Company Information Table 139. Generay Biotech Business Overview Table 140. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 142. Generay Biotech Recent Development Table 143. Benegene Company Information Table 144. Benegene Business Overview Table 145. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 147. Benegene Recent Development Table 148. Shanghai Biochip Company Information Table 149. Shanghai Biochip Business Overview Table 150. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 152. Shanghai Biochip Recent Development Table 153. GENESKY Company Information Table 154. GENESKY Business Overview Table 155. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 157. GENESKY Recent Development Table 158. HD Biosciences Company Information Table 159. HD Biosciences Business Overview Table 160. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio Table 162. HD Biosciences Recent Development Table 163. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2026) Table 166. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Country (2027-2032) Table 168. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2026) Table 171. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2026) Table 176. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Country (2027-2032) Table 178. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2026) Table 181. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2026) Table 186. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Single Nucleotide Polymorphism (SNP) Genotyping Product Image Figure 3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032) & (US$ Million) Figure 5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region: 2025 VS 2032 Figure 6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Region (2021-2032) Figure 7. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Transversion Image Figure 13. Global Transversion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Transition Image Figure 15. Global Transition Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Type 2025 VS 2032 Figure 18. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032) Figure 19. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032) Figure 21. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Type (2021-2032) Figure 23. Diagnostics Image Figure 24. Global Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Animal Image Figure 26. Global Animal Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Plant Image Figure 28. Global Plant Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Research Image Figure 30. Global Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Application 2025 VS 2032 Figure 35. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032) Figure 36. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032) Figure 38. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 45. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 48. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 51. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 54. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Transversion
  • Transition
Applications
  • Diagnostics
  • Animal
  • Plant
  • Research
  • Others
Companies covered
  • Illumina
  • Affymetrix
  • Applied Biosystems
  • Agilent Technologies
  • Beckman Coulter
  • Roche
  • Qiagen
  • Luminex Corporation
  • Enzo Life Sciences
  • Bio-rad
  • Sequenom
  • Ocimum Biosolutions
  • GE Healthcare
  • GenScript
  • Douglas Scientific
  • BGI
  • Beijing Sunbiotech
  • HuaGene Biotech
  • Generay Biotech
  • Benegene
  • Shanghai Biochip
  • GENESKY
  • HD Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2032)
  5. 1.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2021-2026)
  6. 1.4.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Region (2027-2032)
  7. 1.5 Key Regions Single Nucleotide Polymorphism (SNP) Genotyping Market Size (2021-2032)
  8. 1.5.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (2021-2032)
2 Single Nucleotide Polymorphism (SNP) Genotyping Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Transversion
  3. 2.1.2 Transition
  4. 2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Type
  5. 2.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions
  9. 2.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Type (2021-2026)
3 Single Nucleotide Polymorphism (SNP) Genotyping Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Diagnostics
  3. 3.1.2 Animal
  4. 3.1.3 Plant
  5. 3.1.4 Research
  6. 3.1.5 Others
  7. 3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application
  8. 3.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions
  12. 3.3.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Single Nucleotide Polymorphism (SNP) Genotyping Industry Trends
  2. 4.2 Single Nucleotide Polymorphism (SNP) Genotyping Industry Drivers
  3. 4.3 Single Nucleotide Polymorphism (SNP) Genotyping Industry Opportunities and Challenges
  4. 4.4 Single Nucleotide Polymorphism (SNP) Genotyping Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Single Nucleotide Polymorphism (SNP) Genotyping Revenue (2021-2026)
  2. 5.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Key Company Headquarters & Area Served
  4. 5.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Company, Product Type & Application
  5. 5.5 Global Single Nucleotide Polymorphism (SNP) Genotyping Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Single Nucleotide Polymorphism (SNP) Genotyping Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 Affymetrix
  8. 6.2.1 Affymetrix Company Information
  9. 6.2.2 Affymetrix Business Overview
  10. 6.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  12. 6.2.5 Affymetrix Recent Developments
  13. 6.3 Applied Biosystems
  14. 6.3.1 Applied Biosystems Company Information
  15. 6.3.2 Applied Biosystems Business Overview
  16. 6.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  18. 6.3.5 Applied Biosystems Recent Developments
  19. 6.4 Agilent Technologies
  20. 6.4.1 Agilent Technologies Company Information
  21. 6.4.2 Agilent Technologies Business Overview
  22. 6.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  24. 6.4.5 Agilent Technologies Recent Developments
  25. 6.5 Beckman Coulter
  26. 6.5.1 Beckman Coulter Company Information
  27. 6.5.2 Beckman Coulter Business Overview
  28. 6.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  30. 6.5.5 Beckman Coulter Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Roche Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Qiagen
  38. 6.7.1 Qiagen Company Information
  39. 6.7.2 Qiagen Business Overview
  40. 6.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  42. 6.7.5 Qiagen Recent Developments
  43. 6.8 Luminex Corporation
  44. 6.8.1 Luminex Corporation Company Information
  45. 6.8.2 Luminex Corporation Business Overview
  46. 6.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  48. 6.8.5 Luminex Corporation Recent Developments
  49. 6.9 Enzo Life Sciences
  50. 6.9.1 Enzo Life Sciences Company Information
  51. 6.9.2 Enzo Life Sciences Business Overview
  52. 6.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  54. 6.9.5 Enzo Life Sciences Recent Developments
  55. 6.10 Bio-rad
  56. 6.10.1 Bio-rad Company Information
  57. 6.10.2 Bio-rad Business Overview
  58. 6.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  60. 6.10.5 Bio-rad Recent Developments
  61. 6.11 Sequenom
  62. 6.11.1 Sequenom Company Information
  63. 6.11.2 Sequenom Business Overview
  64. 6.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  66. 6.11.5 Sequenom Recent Developments
  67. 6.12 Ocimum Biosolutions
  68. 6.12.1 Ocimum Biosolutions Company Information
  69. 6.12.2 Ocimum Biosolutions Business Overview
  70. 6.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  72. 6.12.5 Ocimum Biosolutions Recent Developments
  73. 6.13 GE Healthcare
  74. 6.13.1 GE Healthcare Company Information
  75. 6.13.2 GE Healthcare Business Overview
  76. 6.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  78. 6.13.5 GE Healthcare Recent Developments
  79. 6.14 GenScript
  80. 6.14.1 GenScript Company Information
  81. 6.14.2 GenScript Business Overview
  82. 6.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  84. 6.14.5 GenScript Recent Developments
  85. 6.15 Douglas Scientific
  86. 6.15.1 Douglas Scientific Company Information
  87. 6.15.2 Douglas Scientific Business Overview
  88. 6.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  90. 6.15.5 Douglas Scientific Recent Developments
  91. 6.16 BGI
  92. 6.16.1 BGI Company Information
  93. 6.16.2 BGI Business Overview
  94. 6.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BGI Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  96. 6.16.5 BGI Recent Developments
  97. 6.17 Beijing Sunbiotech
  98. 6.17.1 Beijing Sunbiotech Company Information
  99. 6.17.2 Beijing Sunbiotech Business Overview
  100. 6.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  102. 6.17.5 Beijing Sunbiotech Recent Developments
  103. 6.18 HuaGene Biotech
  104. 6.18.1 HuaGene Biotech Company Information
  105. 6.18.2 HuaGene Biotech Business Overview
  106. 6.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  108. 6.18.5 HuaGene Biotech Recent Developments
  109. 6.19 Generay Biotech
  110. 6.19.1 Generay Biotech Company Information
  111. 6.19.2 Generay Biotech Business Overview
  112. 6.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  114. 6.19.5 Generay Biotech Recent Developments
  115. 6.20 Benegene
  116. 6.20.1 Benegene Company Information
  117. 6.20.2 Benegene Business Overview
  118. 6.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  120. 6.20.5 Benegene Recent Developments
  121. 6.21 Shanghai Biochip
  122. 6.21.1 Shanghai Biochip Company Information
  123. 6.21.2 Shanghai Biochip Business Overview
  124. 6.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  126. 6.21.5 Shanghai Biochip Recent Developments
  127. 6.22 GENESKY
  128. 6.22.1 GENESKY Company Information
  129. 6.22.2 GENESKY Business Overview
  130. 6.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  132. 6.22.5 GENESKY Recent Developments
  133. 6.23 HD Biosciences
  134. 6.23.1 HD Biosciences Company Information
  135. 6.23.2 HD Biosciences Business Overview
  136. 6.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Product Portfolio
  138. 6.23.5 HD Biosciences Recent Developments
7 North America
  1. 7.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  3. 7.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  3. 8.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  3. 10.3 South America Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst